PlainPharmaWatch

CMS Open Payments · Program Year 2024

Roche Molecular Systems, Inc.

Roche Molecular Systems, Inc. reported $15,181,827.23 in payments to 813 physicians and teaching hospitals across 1,376 transactions.

See the rankings → How this is sourced
$15.2M
Total payments
1,376
Transactions
813
Recipients
−$263.4K
General Payments vs PY2023

Roche Molecular Systems, Inc. reported $15,181,827.23 in payments to 813 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #125 of 1,925 reporting manufacturers (0.1% of all US industry payments), averaging $18.7K per recipient across 7 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Roche Molecular Systems, Inc. pairs top-10% payment volume with a broadly spread payment pattern across many recipients.

#125
of 1,925 companies
0.1%
of all US industry payments
0.1%
paid to its single top recipient
7
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Roche Molecular Systems, Inc.'s CMS-reported General Payments decreased by $263.4K (−6.9%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: ROCHE MOLECULAR SYSTEMS, INC.PY2023: ROCHE MOLECULAR SYSTEMS, INC.PY2024: ROCHE MOLECULAR SYSTEMS, INC.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$3.8MPY2024$3.5M
PY2023
$3,811,037.68
PY2024
$3,547,620.76

How Roche Molecular Systems, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Roche Molecular Systems, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$15,181,827 Top 6% higher than 94% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). Below this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Below this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). This entry sits in this band. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Roche Molecular Systems, Inc.

In Program Year 2024, Roche Molecular Systems, Inc. reported $15,181,827.23 in payments to 813 physicians and teaching hospitals across 1,376 individual transactions, an average of $11.0K per transaction and $18.7K per recipient. That total places Roche Molecular Systems, Inc. at rank #125 out of 1,925 companies in the CMS Open Payments database, representing 0.1% of all industry payments reported nationwide for the year.

"Compensation for Services Other Than Consulting" leads the 7-category general-payment breakdown below at $3.0M (20.1% of the company's reported total, 602 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

Roche Molecular Systems, Inc. made 7 types of general payments. "Compensation for Services Other Than Consulting" is the largest category at $3.0M, 20.1% of the company's reported total.

How Roche Molecular Systems, Inc. divides its payments

General-payment categories, ordered by reported total

1. Compensation for Services…$3.0M2. Consulting Fee$369.9K3. Travel and Lodging$85.1K4. Royalty or License$24.2K5. Education$13.3K6. Grant$4.0K7. Food and Beverage$4.0K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $3.0M 602
Consulting Fee $369.9K 53
Travel and Lodging $85.1K 85
Royalty or License $24.2K 5
Education $13.3K 16
Grant $4.0K 1
Food and Beverage $4.0K 51

Recipient Concentration in General Payments

The five largest recipient relationships account for $1,662,097.58 (46.9%) of $3,547,620.76 in this company's General Payments records across 101 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Roche Molecular Systems, Inc.

The five named recipients with the highest reported General Payments from this company

Guadalupe Manriquez$413.9KGordana Juric-Sekhar$381.5KGhassan Tranesh$339.5KMichael Lynch$289.4KGruschenka Mojica Sanchez$237.8K
  1. 1

    Guadalupe Manriquez

    $413,875.70 across 39 reported transactions

  2. 2

    Gordana Juric-Sekhar

    $381,500.82 across 44 reported transactions

  3. 3

    Ghassan Tranesh

    $339,511.35 across 39 reported transactions

  4. 4

    Michael Lynch

    $289,421.30 across 50 reported transactions

  5. 5

    Gruschenka Mojica Sanchez

    $237,788.41 across 41 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $11.0K. Average per recipient: $18.7K.

Total Amount

$15,181,827.23

Avg per Transaction

$11.0K

Avg per Recipient

$18.7K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Roche Molecular Systems, Inc. Share

0.1%

#125 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Roche Molecular Systems, Inc.

Biosense Webster, Inc.

$15.3M 28,126 recipients

Roche TCRC, Inc.

$15.4M 1 recipients

Roche Diagnostics Operations, Inc.

$14.9M 0 recipients

Otsuka Pharmaceutical Development & Commercialization, Inc.

$14.8M 4,515 recipients

Swedish Orphan Biovitrum Ab

$14.7M 55 recipients

Philips North America LLC

$15.7M 35,252 recipients

Frequently Asked Questions

How much did Roche Molecular Systems, Inc. pay to physicians and hospitals in 2024? ▾
In Program Year 2024, CMS Open Payments recorded $15,181,827.23 from Roche Molecular Systems, Inc. to physicians and hospitals across 1,376 transactions - 0.1% of all industry payments reported that year.
How many physicians received payments from Roche Molecular Systems, Inc.? ▾
Roche Molecular Systems, Inc. made payments to 813 physicians and teaching hospitals in 2024. The average payment per recipient was $18.7K.
What types of payments did Roche Molecular Systems, Inc. make? ▾
General payments from Roche Molecular Systems, Inc. span 7 distinct categories, covering things like consulting, meals, and travel. The largest general-payment category was "Compensation for Services Other Than Consulting" at $3.0M, representing 20.1% of the company's reported total.
How does Roche Molecular Systems, Inc. rank among pharmaceutical companies? ▾
Out of 1,925 companies in the CMS Open Payments database for 2024, Roche Molecular Systems, Inc. ranks #125 by total payment amount.
What is the average payment size from Roche Molecular Systems, Inc.? ▾
In 2024, Roche Molecular Systems, Inc. averaged $11.0K per transaction across 1,376 transactions to 813 recipients.
Where does the payment data for Roche Molecular Systems, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Roche Molecular Systems, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.